ArticleSignal transduction and targeted therapy2020

p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer.

Xiaoli Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.